ATE551596T1 - Arzneistoffauthentisierung - Google Patents
ArzneistoffauthentisierungInfo
- Publication number
- ATE551596T1 ATE551596T1 AT04784722T AT04784722T ATE551596T1 AT E551596 T1 ATE551596 T1 AT E551596T1 AT 04784722 T AT04784722 T AT 04784722T AT 04784722 T AT04784722 T AT 04784722T AT E551596 T1 ATE551596 T1 AT E551596T1
- Authority
- AT
- Austria
- Prior art keywords
- disclosed
- product
- counterfeiting
- order
- medicinal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3563—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing solids; Preparation of samples therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6402—Atomic fluorescence; Laser induced fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/88—Investigating the presence of flaws or contamination
- G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
- G01N21/9508—Capsules; Tablets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Collating Specific Patterns (AREA)
- Air-Conditioning For Vehicles (AREA)
- Transmission And Conversion Of Sensor Element Output (AREA)
- Materials For Photolithography (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50477403P | 2003-09-22 | 2003-09-22 | |
| PCT/US2004/030977 WO2005031302A2 (en) | 2003-09-22 | 2004-09-22 | Drug authentication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE551596T1 true ATE551596T1 (de) | 2012-04-15 |
Family
ID=34392943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04784722T ATE551596T1 (de) | 2003-09-22 | 2004-09-22 | Arzneistoffauthentisierung |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8719043B2 (de) |
| EP (1) | EP1671094B1 (de) |
| AT (1) | ATE551596T1 (de) |
| WO (1) | WO2005031302A2 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060283931A1 (en) * | 2003-09-22 | 2006-12-21 | University Of Maryland, Baltimore | Product authentication |
| WO2005031302A2 (en) | 2003-09-22 | 2005-04-07 | University Of Maryland, Baltimore | Drug authentication |
| US20050225758A1 (en) * | 2004-03-23 | 2005-10-13 | Knopp Kevin J | Raman optical identification tag |
| JP2008502058A (ja) * | 2004-05-18 | 2008-01-24 | シルバーブルック リサーチ ピーティワイ リミテッド | セキュリティ文書を追跡する方法およびコンピュータシステム |
| US7930064B2 (en) | 2004-11-19 | 2011-04-19 | Parata Systems, Llc | Automated drug discrimination during dispensing |
| US8247018B2 (en) * | 2005-06-20 | 2012-08-21 | Authentiform Technologies, Llc | Methods for quality control |
| US20090004231A1 (en) * | 2007-06-30 | 2009-01-01 | Popp Shane M | Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring |
| US9058615B2 (en) * | 2007-10-02 | 2015-06-16 | Elady Limited | Product evaluation system and product evaluation method |
| US7647193B2 (en) * | 2008-01-23 | 2010-01-12 | International Business Machines Corporation | Authentication of pharmaceuticals using molecular computational identification |
| WO2010011833A1 (en) * | 2008-07-23 | 2010-01-28 | Alexander Stuck | Secure tracking of tablets |
| US8626672B2 (en) * | 2008-07-23 | 2014-01-07 | I-Property Holding Corp. | Secure tracking of tablets |
| US8284386B2 (en) | 2008-11-26 | 2012-10-09 | Parata Systems, Llc | System and method for verifying the contents of a filled, capped pharmaceutical prescription |
| US8374965B2 (en) | 2008-11-26 | 2013-02-12 | Parata Systems, Llc | System and method for verifying the contents of a filled, capped pharmaceutical prescription |
| US9189728B2 (en) * | 2009-07-23 | 2015-11-17 | I-Property Holding Corp. | Method for the authentication of dosage forms |
| DE202009012784U1 (de) * | 2009-09-23 | 2011-02-10 | Steinweg, Detlef | Vorrichtung zur Kontrolle des Inhalts Medikamente enthaltender Packungseinheiten |
| SG186283A1 (en) | 2010-06-14 | 2013-01-30 | Trutag Technologies Inc | System for producing a packaged item with an identifier |
| WO2012138236A1 (en) | 2011-04-06 | 2012-10-11 | Krouse Donal Paul | Spectroscopic analyser |
| US20120278096A1 (en) * | 2011-04-28 | 2012-11-01 | David Anthony Holness | Methods and systems for prescription drug authentication in supply chain and market distribution |
| US8534543B1 (en) * | 2012-05-18 | 2013-09-17 | Sri International | System and method for authenticating a manufactured product with a mobile device |
| EP2915098A4 (de) | 2012-10-30 | 2016-07-06 | Certirx Corp | Produkt-, bild- oder dokumentenauthentifizierung und -verifizierung und objektidentifikation |
| US20140350945A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | System and Method for Validation of Pharmaceutical Composition Formulations |
| US20140350946A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | Methods for Tracking Workflow in Pharmacies Involving Compound Operations |
| EP2821940A1 (de) | 2013-07-03 | 2015-01-07 | Lumiprobe GmbH | Binäre Etikettierung |
| US20160019366A1 (en) * | 2014-07-17 | 2016-01-21 | Paul P. Klomp | Method for Validation of Pharmaceutical Composition Formulations |
| WO2016072874A1 (en) | 2014-11-07 | 2016-05-12 | Fernando Cruz - Promoções Técnico Cientificas, Unipessoal Lda | Method for encoding pharmaceutical solid forms with an authentication code, a bulk powder encoding device and a product certification process |
| US11042738B2 (en) * | 2015-04-23 | 2021-06-22 | I-Property Holding Corp. | Simple authentication of elements in blister packages |
| US10330592B2 (en) | 2017-07-21 | 2019-06-25 | Serguei Koulikov | Laser absorption spectroscopy isotopic gas analyzer |
| WO2019169196A1 (en) | 2018-02-28 | 2019-09-06 | Tri-Star Technologies | Apparatus, system and method for facilitating tracking of consumable pharmaceutical articles |
| PL427437A1 (pl) * | 2018-10-16 | 2020-04-20 | Instytut Biotechnologii I Medycyny Molekularnej | Sposób chemicznego znakowania tabletek z wykorzystaniem otoczki |
| US11094407B2 (en) * | 2019-06-13 | 2021-08-17 | International Business Machines Corporation | Electronics miniaturization platform for medication verification and tracking |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE446299B (sv) * | 1978-04-11 | 1986-09-01 | Kureha Chemical Ind Co Ltd | Medicinsk komposition innehallande ett derivat av para-aminobensoesyra som aktiv bestandsdel |
| US5679954A (en) * | 1994-11-14 | 1997-10-21 | Soloman; Sabrie | Non-destructive identification of tablet and tablet dissolution by means of infared spectroscopy |
| US6232124B1 (en) | 1996-05-06 | 2001-05-15 | Verification Technologies, Inc. | Automated fingerprint methods and chemistry for product authentication and monitoring |
| GB2313188B (en) * | 1996-05-17 | 1999-10-20 | Pfizer Ltd | Spectrophotometric analysis |
| US6490030B1 (en) | 1999-01-18 | 2002-12-03 | Verification Technologies, Inc. | Portable product authentication device |
| GB2347739A (en) * | 1999-03-09 | 2000-09-13 | Pfizer Ltd | Powder Analysis |
| WO2001003646A2 (en) | 1999-07-14 | 2001-01-18 | Spectral Dimensions, Inc. | High-volume on-line spectroscopic composition testing of manufactured pharmaceutical dosage units |
| US6395538B1 (en) | 1999-07-16 | 2002-05-28 | Human Genome Sciences, Inc. | Method and system for providing real-time, in situ biomanufacturing process monitoring and control in response to IR spectroscopy |
| FR2804784B1 (fr) * | 2000-02-04 | 2003-04-11 | Novatec | Procede universel d'identification et d'authentification d'objets, de vegetaux ou d'etres vivants |
| US6765212B2 (en) * | 2001-02-12 | 2004-07-20 | Analytical Spectral Devices, Inc. | System and method for combining reflectance data |
| US6907351B2 (en) | 2001-08-01 | 2005-06-14 | Aventis Animal Nutrition S.A. | Customer-based prediction method and system using near infrared reflectance spectra of materials |
| WO2003060443A1 (en) * | 2001-12-21 | 2003-07-24 | Spectral Dimensions, Inc. | Spectrometric process monitoring |
| US6771369B2 (en) * | 2002-03-12 | 2004-08-03 | Analytical Spectral Devices, Inc. | System and method for pharmacy validation and inspection |
| WO2004072868A1 (en) * | 2003-02-10 | 2004-08-26 | Verication, L.L.C. | Database and method of use for authenticity verification of pharmaceuticals |
| US7682523B2 (en) | 2003-09-05 | 2010-03-23 | William Marsh Rice University | Fluorescent security ink using carbon nanotubes |
| WO2005031302A2 (en) | 2003-09-22 | 2005-04-07 | University Of Maryland, Baltimore | Drug authentication |
| US20060283931A1 (en) * | 2003-09-22 | 2006-12-21 | University Of Maryland, Baltimore | Product authentication |
| US20060062734A1 (en) | 2004-09-20 | 2006-03-23 | Melker Richard J | Methods and systems for preventing diversion of prescription drugs |
| WO2010120555A2 (en) * | 2009-03-31 | 2010-10-21 | The U.S.A, As Represented By The Secretary,Dpt. Of Health & Human Services | Device and method for detection of counterfeit pharmaceuticals and/or drug packaging |
-
2004
- 2004-09-22 WO PCT/US2004/030977 patent/WO2005031302A2/en not_active Ceased
- 2004-09-22 US US10/572,912 patent/US8719043B2/en active Active
- 2004-09-22 AT AT04784722T patent/ATE551596T1/de active
- 2004-09-22 EP EP04784722A patent/EP1671094B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1671094B1 (de) | 2012-03-28 |
| US20070086625A1 (en) | 2007-04-19 |
| US8719043B2 (en) | 2014-05-06 |
| EP1671094A4 (de) | 2010-05-12 |
| WO2005031302A2 (en) | 2005-04-07 |
| EP1671094A2 (de) | 2006-06-21 |
| WO2005031302A3 (en) | 2007-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE551596T1 (de) | Arzneistoffauthentisierung | |
| WO2007117867A3 (en) | Product authentication | |
| Gewandter et al. | A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors | |
| Ritz et al. | Benefits and risks of bariatric surgery in patients aged more than 60 years | |
| WO2006119480A3 (en) | Website reputation product architecture | |
| NO20074032L (no) | Medisinleveringssystem | |
| WO2007143676A3 (en) | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms | |
| EP1140840A4 (de) | -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren | |
| WO2007002009A3 (en) | Product authentication | |
| ATE537870T1 (de) | Periphere nervenfeldstimulation und rückenmarksstimulation | |
| WO2006135751A3 (en) | Combination therapy including peripheral nerve field stimulation | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| AU2003216884A1 (en) | Plant extracts and the use thereof | |
| Tacchini et al. | Mycochemicals against cancer stem cells | |
| WO2005011590A3 (en) | Compositions and methods for restoring sensitivity to treatment with her2 antagonists | |
| NO20083307L (no) | Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring | |
| NO20080035L (no) | Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
| Money et al. | Review of under-recognized adjunctive therapies for cancer | |
| Kochoian et al. | Targeting striatal glutamate and phosphodiesterases to control L-DOPA-induced dyskinesia | |
| NO20080034L (no) | Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
| BRPI0804070A2 (pt) | usos do domìnio intracitoplasmático da proteìna da quinase de linfoma anaplástico e de uma molécula de ácido nucleico, e, produto | |
| SE0403152L (sv) | Spektroskopiskt förfarande | |
| WO2005076941A3 (en) | Separate trading of registered interest and principal of securities system, method and computer program product | |
| Wang et al. | Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming—A New Mechanism for SCLC Chemoresistance Boosted by Nicotine | |
| Dobi et al. | Irinotecan (CPT-11) canonical anti-cancer drug can also modulate antiviral and pro-inflammatory responses of primary human synovial fibroblasts |